Key Takeaways Core Laboratories cut Q1 2026 guidance due to the Middle East conflict disrupting operations and demand.CLB faces project delays, supply chain issues and restricted mobility, impacting execution timelines.Reservoir Description is hit hardest, while Production Enhancement sees delays but remains resilient.Core Laboratories Inc. (CLB) has warned that escalating geopolitical tensions in the Middle East are set to weigh on its first-quarter 2026 financial performance. The company is actively asses ...